Browsing Tag
uPAR
1 post
Curasight enters clinic with uTREAT for glioblastoma, advancing dual radiopharma strategy
Curasight starts first-in-human trial of uTREAT in glioblastoma, launching its therapeutic radiopharmaceutical program. Read the full strategic analysis.